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Gram-negative bacteria secrete outer membrane vesicles that deliver lipopolysaccharide (LPS) to the host cell cytosol, where it can trigger caspase-11 activation-a critical mechanism against bacterial infections and to sepsis pathogenesis.
INTRODUCTION
The compartmentalization of the innate immune system enables it to mount customized immune responses to pathogens based on the subcellular localization of microbial products (Brubaker et al., 2015) . Toll-like receptors (TLRs) sense microbial products at the cell surface and within endosomes inducing NFkB/IRF3-mediated transcriptional responses. A second set of receptors in the cytosol recognizes the same microbial products, but triggers markedly distinct responses, the hallmark of which is the activation of inflammasomes. Inflammasomes are multi-protein complexes comprised of a sensor such as an NLR protein, an adaptor protein, ASC, and the protease caspase-1. A multitude of microbial signals such as toxins, flagellin, and nucleic acids can trigger inflammasome assembly resulting in caspase-1 activation (Rathinam et al., 2012a) . Caspase-1 processes pro-IL-1b and pro-IL-18 into active forms and cleaves gasdermin D to trigger pyroptosis, an inflammatory cell death (He et al., 2015; Kayagaki et al., 2015; Shi et al., 2015) .
The latest addition to the repertoire of immune surveillance mechanisms in the cytosol is a new lipopolysaccharide (LPS)-sensing pathway. LPS was considered to be exclusively detected at the cell surface by TLR4, in combination with MD2 and CD14, leading to transcriptional regulation of gene expression (Park et al., 2009; Poltorak et al., 1998) . Recent studies have discovered that the host is capable of TLR4-independent recognition of LPS in the cytosol (Hagar et al., 2013; Kayagaki et al., 2013) . Inflammatory caspases, namely caspase-11 in mice and caspase-4 and caspase-5 in humans, are considered as the receptors for cytosolic LPS (Shi et al., 2014) . Caspase-11 binds cytosolic LPS leading to its own activation, which together with NLRP3 and ASC, triggers caspase-1 activation. Interestingly, caspase-11 also directly cleaves gasdermin D mediating pyroptosis in a NLRP3-and caspase-1-independent manner (Kayagaki et al., 2011 (Kayagaki et al., , 2015 Shi et al., 2014 Shi et al., , 2015 . The cytosolic entry of LPS thus stimulates responses that are entirely distinct from the responses to TLR4-recognition of extracellular LPS, and therefore LPS accessing the cytosol is a critical event. During infections with cytosolic bacteria such as Burkholderia and Shigella, LPS may gain access to the cytosol owing to the cytosolic niche of bacteria. However, most Gram-negative bacteria that activate caspase-11 including enterohemorrhagic Escherichia coli (EHEC), Vibrio cholerae, Citrobacter rodentium, and Haemophilus influenzae are not cytosolic (Gurung et al., 2012; Kailasan Vanaja et al., 2014; Meunier et al., 2014; Rathinam et al., 2012b) raising an intriguing question of how LPS from these Gram-negative bacteria gains access to the cytosol.
Gram-negative bacteria secrete outer membrane vesicles (OMVs), which are 20-250 nm in diameter. OMVs are not a byproduct of bacterial cell wall damage or lysis but bona fide secretory vesicles produced in a programmed fashion (Ellis and Kuehn, 2010) . LPS is one of the most abundant components of OMVs. Bacteria secrete OMVs at increased levels upon exposure to stressful conditions such as host milieu, and OMVs enable bacteria to communicate with host cells and deliver their products intracellularly to modulate cellular functions. Therefore, OMVs, similar to eukaryotic exosomes/microvesicles, are an efficient inter-cellular communication mechanism (Demuth et al., 2003; Galka et al., 2008; Kesty et al., 2004) . Previous studies showed that purified OMVs are immunostimulatory (Kim et al., 2013; Park et al., 2010) , and OMV-associated peptidoglycan has been shown to activate NOD signaling and NF-kB activation (Bonham and Kagan, 2014; Kaparakis et al., 2010) . Furthermore, OMVs produced by gut microbiota play an immunomodulatory role in mucosal immunity (Hickey et al., 2015; Shen et al., 2012) . Thus, OMVs facilitate the trans-kingdom or inter-kingdom communication between the host and microbes in pathogenic as well as symbiotic contexts.
Here, we identified OMVs as the vehicle that mediates the cytosolic localization of LPS during extra cellular Gram-negative bacterial infections. Following their clathrin-mediated endocytic uptake, OMVs deliver LPS into the cytosol from early endocytic compartments. Consequently, OMVs activate the cytosolic LPSsensing pathway leading to pyroptosis and caspase-1 activation. Demonstrating a necessary role for OMVs for intracellular LPS release during bacterial infections, genetic attenuation of bacterial OMV production diminishes their ability to activate caspase-11-dependent cell death and IL-1 responses. Collectively, these findings reflect OMVs as a biologically relevant means by which LPS enters the cell during bacterial infections. In broader terms, our data reveal a fundamental mechanism that delivers pathogen-associated molecular patterns (PAMPs) into the cytosol to alert the immune system. In order to mount optimal immune responses, the host should be able to recognize not only PAMPs but also cues indicative of harmful infections (Vance et al., 2009) . Since OMVs are produced by live replicating bacteria and alert cytosolic surveillance mechanisms, OMVs with immunostimulatory PAMPs can be considered as a critical contextual cue for infections that pose serious threat to the host.
RESULTS

LPS Gains Access to the Cytosol during Extracellular
Gram-Negative Bacterial Infections LPS entry into the cytosol is a critical step in the caspase-11-driven noncanonical inflammasome responses to Gram-negative bacteria. However, the majority of the Gram-negative bacteria such as EHEC that activate this cytosolic LPS sensing pathway are extracellular and excluded from the cytosol owing to their susceptibility to the bactericidal mechanisms of phagolysosomes (Kailasan Vanaja et al., 2014) . Given this, we sought to determine if LPS actually enters the cytosol during an extracellular Gram-negative bacterial infection by employing four independent approaches. First, we extracted cytosol from uninfected or EHEC-infected bone marrow-derived macrophages (BMDMs) using digitonin and assessed LPS levels with the limulus amebocyte lysate (LAL) assay. Digitonin is commonly used to isolate cytosol (Ramsby and Makowski, 2005) , and the use of an extremely low concentration of digitonin (0.005%) for a very short duration allowed extraction of cytosol devoid of plasma membrane, early and late endosomes, and lysosomes (Na + /K + ATPase, EEA1, Rab7, and Lamp1, respectively; Figure 1A) . By subjecting the cytosol fraction and the residual non-cytosolic fraction (that includes the plasma membrane and the organelles such as endosomes and lysosomes) to LAL assay, we found that LPS was present in the cytosol of infected but not uninfected cells ( Figure 1B ). In contrast, we did not recover any bacteria from the cytosol by agar plating ( Figure 1C ), indicating that LPS detected in the cytosol is not from bacteria escaping into the cytosol. On the other hand, the residual noncytosolic fraction contained a considerable number of bacteria and consequently a significant amount of LPS ( Figures 1B and  1C) . Similar results were obtained for the cytosol extracted using a standard non-detergent method (Sun et al., 2013) in which cells were mechanically lysed in hypotonic buffer ( Figures 1D-1F ). Additionally, the cytosolic level of LPS increased over time and a significantly higher amount of LPS was observed in the cytosol at 16 hr compared to 4 hr ( Figure S1A ) resulting in a proportional increase in cell death, a direct outcome of cytosolic LPS-mediated caspase-11 activation ( Figure S1B ).
To visualize the cytosolic localization of LPS during EHEC infection, BMDMs infected with EHEC were stained with antibodies against LPS or lipid A as well as endosomal or lysosomal markers and analyzed using confocal microscopy. At 4 hr of infection, distinct LPS or lipid A foci in the cytosol that did not associate with early endosomes, late endosomes, or lysosomes were found ( Figures 1G and S1C ). Approximately 30%-40% of the infected cells contained these cytosolic LPS foci whereas no LPS or lipid A foci were detected in uninfected cells ( Figures  S1D and S1E) . Furthermore, transmission electron microscopy (TEM) of EHEC-infected cells following immunogold staining for LPS showed the presence of LPS in the cytosol (outside membrane-bound organelles; Figure 1H ) and bacteria in phagosome-like structures but not in the cytosol ( Figure S1F ). Collectively, these data clearly demonstrate the cytosolic localization of LPS but not bacteria during an extracellular Gram-negative bacterial infection.
Bacterial OMVs Deliver LPS into the Cytosol The above observations raise an intriguing question: how does LPS from extracellular bacteria such as EHEC enter the cytosol? To test if bacterial phagocytosis is required for cytosolic LPS entry in EHEC infection, LPS was quantified in the cytosol fraction extracted from cells treated with cytochalasin D prior to infection with EHEC. Cytochalasin D treatment completely inhibited EHEC attachment and phagocytosis as no bacteria were recovered from cytosolic or non-cytosolic residual fractions (Figure 2A) . Contrastingly, cytochalasin D treatment did not affect LPS levels in the cytosol ( Figure 2B) showing that LPS entry into the cytosol occurs regardless of bacterial phagocytosis. Further confirming this, EHEC-induced caspase-11-dependent cell death was not altered by cytochalasin D pretreatment ( Figures 2C and S2A) .
It is possible that LPS may be released from bacteria in the extracellular space and this free LPS diffuses across the plasma membrane into the cytosol. However, when purified free LPS is added to the macrophage culture, it does not enter the cytosol ( Figure S2B ) and it has to be introduced into the cytosol by transfection to activate the cytosolic LPS sensing pathway and subsequent cell death ( Figure S2C ). Alternately, LPS could be delivered into the cytosol by bacterial type III secretion system (T3SS), which injects bacterial factors into the host cell via a needle-like structure. However, EHEC mutants lacking T3SS (DLEE) or Tir (Dtir), a key T3SS protein required for the initiation of the needle-like structure, induced equivalent levels of cell death as wild-type EHEC arguing against this possibility ( Figure 2D ). Furthermore, E. coli BL21, a laboratory strain of E. coli that does not contain T3SS or other virulence factors, induced comparable levels of cell death as EHEC further confirming the dispensability of T3SS and other virulence factors in LPS delivery ( Figure 2E ). In contrast, heat-killed EHEC and E. coli BL21 failed to induce cell death indicating that viability of bacteria is essential for cytosolic LPS entry ( Figure 2F ). This inability of heat-killed bacteria to activate cytosolic LPS sensing was attributable more to failure to deliver LPS into the cell than to lack of LPS itself as heat-killed bacteria have functional LPS (Sander et al., 2011) . Supporting this, transfection of heat-killed bacterial lysate into the macrophages induced cell death similar to live bacteria (Figure 2F) . These observations strongly suggest that a live bacteriaspecific carrier-like mechanism is responsible for the intracellular entry of LPS.
Extracellular vesicles (EVs) produced by eukaryotic and prokaryotic cells are highly specialized secretory mechanisms that mediate cell-to-cell transfer of protein, lipid, and nucleic acid contents (Kulp and Kuehn, 2010) . EV secreted by Gram-negative bacteria known as outer membrane vesicles (OMVs), owing to their size, shape, and membrane composition, interact tightly with plasma and endocytic membranes of host cells and efficiently transfer their content across these membranes (Jä ger et al., 2015; Kuehn and Kesty, 2005) . OMVs are rich in LPS, and OMV-associated LPS is believed to be highly potent (Ellis and Kuehn, 2010) . Taking all these into account, we hypothesized that OMVs secreted by Gram-negative bacteria function as a vehicle to deliver LPS into the cytosol.
During EHEC infection of macrophages, vesicle-like LPS-containing structures with a size similar to that of OMVs were observed by immunoelectron microscopy both in the extracellular ( Figure 2G ) and intracellular ( Figure 2H ) space, suggesting a role for OMVs in the intracellular transport of LPS. To test this, OMVs from E. coli BL21 was purified using established methods (Chutkan et al., 2013) and verified to be devoid of bacterial contamination by electron microscopy ( Figure 2I ) and agar plating (data not shown). OMVs have the characteristic lipid bilayer structure ( Figure 2I ) and contain a significant amount of LPS ( Figure 2J ). BMDMs were treated with purified E. coli OMVs and monitored for the presence of LPS in the cytosol by LAL assay and confocal microscopy. Cytosolic fractions from OMV-treated BMDMs contained substantial amounts of LPS ( Figure 2K ). Furthermore, OMV delivery of LPS was more (legend continued on next page) efficient with a relatively faster kinetics than that by chemical transfection ( Figure S2D ). Similar to EHEC infection ( Figure 2B ), LPS release in the cytosol by OMVs was not affected by pretreatment of cells with cytochalasin D (Figure 2K) . Likewise, confocal microscopy demonstrated LPS and lipid A specks in the macrophage cytosol that were not associated with early endosomes, lysosomes, or cell membrane following OMV treatment ( Figures  2L and S2E ). More than 50% of the cells contained LPS specks in the cytosol 4 hr after OMV treatment. We also observed colocalization of these intracellular LPS specks with caspase-11 in cells stimulated with OMVs or EHEC ( Figure S2F ). Cytosolic LPS sensing also exists in nonphagocytic cells such as HeLa (Shi et al., 2014) , where bacteria like EHEC remain extracellular and OMVs might become more important in enabling intracellular transport of LPS. In line with this idea, subcellular fractionation followed by LAL assay showed the presence of substantial amounts of LPS in the cytosol of HeLa cells upon treatment with OMVs or EHEC ( Figure 2M ).
Bacterial OMVs Activate Cell Death and IL-1 Responses
Consistent with the delivery of LPS into the cytosol by OMVs, treatment of BMDMs with purified OMVs triggered caspase-1 and IL-1b proteolytic maturation, IL-1b secretion, and more importantly, cell death in a dose-dependent manner ( Figure 3A) . Furthermore, OMVs elicited pyroptosis and/or IL-1b release in BMDCs, mouse peritoneal resident cells, THP1 macrophages, and HeLa cells indicating that OMVs can intracellularly deliver LPS in an array of cell types including human cells ( Figures  3B-3E ). We next tested if the phenomenon of cytosolic LPS delivery and caspase-11 activation by OMVs is common to extracellular Gram-negative bacteria. Two clinically important bacteria that are well documented to produce OMVs during infections are Neisseria meningitidis and Pseudomonas aeruginosa (Mashburn and Whiteley, 2005; Namork and Brandtzaeg, 2002) . Like E. coli OMVs, both N. meningitidis and P. aeruginosa OMVs triggered pyroptotic cell death and IL-1b secretion in BMDMs ( Figures 3F and 3G ). Overall, OMVs are sufficient for LPS delivery into the cytosol leading to pyroptosis and IL-1 maturation.
OMV-Mediated Activation of Cell Death and IL-1 Is Dependent on LPS and Caspase-11 LPS is one of the most abundant components of OMVs and is displayed on the outer surface of OMVs. In addition, OMVs are also loaded with outer membrane proteins, lipoproteins, and nucleic acids to name a few. To verify that OMV-mediated cell death and IL-1 responses are elicited by LPS and not other bacterial components in OMVs, BMDMs were stimulated with OMVs purified from wild-type E. coli or an E. coli mutant (MKV15) that lacks functional hexa-acylated lipid A and thus caspase-11 activating capacity ( Figure S3 ). OMVs from LPS mutant E. coli failed to induce strong cell death and IL-1a and IL-1b secretion (Figure 4A) . Alternately, to address if LPS is the functional moiety of OMVs that elicit these responses, we pretreated OMVs with polymyxin B, an antibiotic that neutralizes LPS, and tested its effect on inflammasome activation. As expected, polymyxin B-pretreatment of OMVs reduced their capacity to trigger pyroptotic and IL-1 responses ( Figure 4B ). Additionally, membrane vesicles prepared from the Gram-positive bacterium, Listeria monocytogenes, which lacks LPS, did not induce cell death or production of IL-1b and IL-1a ( Figure 4C ). These data clearly show that LPS is the key ingredient of OMVs that activate cell death and IL-1 cytokines. More importantly, cell death, production of IL-1b and IL-1a, as well as cleavage of caspase-1 and IL-1b elicited by OMVs were absolutely dependent on caspase-11 ( Figures 4D-4F) . These data clearly demonstrate that OMVs are indeed activating the caspase-11-mediated LPS sensing pathway in the cytosol.
Bacterial OMVs Attain Intracellular Access through Endocytosis
To gain insight into the mechanism by which OMVs enable cytosolic access of LPS, the localization of OMVs was tracked at various time points following exposure to BMDMs with confocal microscopy. We stained OMV-treated BMDMs with an anti-LPS antibody as a marker of OMVs. Confocal imaging revealed that OMVs bound to the cells and were internalized within 30 min of treatment. After 1 hr of treatment, $25% of the cells contained intracellular LPS specks indicating OMV internalization (Figure 5A ). The proportion of cells containing LPS specks increased over time, and by 12 hr, $80% of cells contained OMVs (Figure 5A) . To delineate the distribution of these intracellular LPS specks in the cytosol versus membrane bound organelles, the cells were also stained with anti-EEA1 or anti-LAMP2 antibodies to visualize early endosomes and lysosomes, respectively, as well as fluorescent cholera toxin B to label cell membranes. At 1 hr of treatment, nearly all of the internalized OMVs colocalized with early endosomal compartments ( Figure 5B ) suggesting that OMVs enter the cells through endocytosis. Notably, albeit at very low frequency, LPS specks were observed outside endosomes in the cytosol starting from 1 hr. The frequency of these cytosolic LPS specks increased over time and at 12 hr >75% of the intracellular LPS specks were in the cytosol ( Figure 5B ). In contrast to its predominant localization in EEA1-stained compartments, LPS specks colocalized with LAMP2-stained lysosomal compartments at low frequency ( Figure S4A ). Given this uptake of OMVs by macrophages, we sought to determine the mechanism underlying the cellular entry of OMVs. Cytosolic LPS delivery by OMVs appears to occur independent of TLR4 and CD14 as pyroptosis and secretion of IL-1b and IL-18 upon OMV treatment were intact in TLR4 OMV uptake ( Figure 5C ). Because OMVs are of appropriate cargo size for clathrin-mediated endocytosis (CME) (McMahon and Boucrot, 2011) , it was reasoned that OMVs may enter the cells via CME. Immunofluorescence staining revealed the colocalization of OMVs with clathrin near the plasma membrane, implying their uptake in clathrin-coated pits ( Figure S4C ). Importantly, we performed small interfering RNA (siRNA)-mediated silencing of the expression of m2 subunit of the AP2 adaptor complex, which is essential for CME (Doherty and McMahon, 2009) and assessed its effect on OMV-driven caspase-11 activation. AP2 knockdown markedly reduced the pyroptotic response to both OMVs and EHEC, without affecting poly(dA:dT)-induced AIM2-dependent cell death ( Figure 5D ; see Figure S4D for knockdown efficiency). Endosomes are directed toward lysosomes to degrade their cargo, raising the question of from where LPS exits the endosomal pathway to reach the cytosol. In our confocal imaging analysis, LPS was observed at a remarkably higher frequency in early endosomes than in lysosomes ( Figures 5B and  S4A ) prompting us to consider if OMV-associated LPS escapes from the early endosome into the cytosol. To test this, the early endosome formation was inhibited by stable knockdown of Rab5 (key GTPase involved in this process) using two independent small hairpin RNAs (shRNAs). Induction of cell death by EHEC and OMVs, but not by poly(dA:dT) and ATP, was substantially reduced by Rab5 knockdown ( Figure 5E ; see Figure S4E for knockdown efficiency). Contrastingly, blocking the maturation of early endosomes to late endosomes by shRNA or siRNA knockdown of Rab7, which is critical for early-to-late endosome transition, did not affect OMV-and EHEC-induced pyroptosis (Figures 5F and 5G; see Figure S4F for knockdown efficiency). Similarly, OMV-and EHEC-induced pyroptosis was insensitive to nocodazole ( Figures 5H and S4G ), which blocks microtubule-dependent progression of early to late endosome. Taken together, the requirement for AP2 complex and Rab5, but not Rab7, reveals that OMVs enter the cells by clathrin-mediated endocytosis, and importantly, LPS accesses the cytosol from early endosomes.
OMVs Are Essential for Cytosolic LPS Access and Caspase-11 Activation during Bacterial Infection Having shown that OMVs are sufficient for cytosolic LPS delivery and caspase-11 activation, we next tested if OMVs are required for LPS to gain access to the cytosol and trigger caspase-11 activation during actual extracellular Gram-negative bacterial infections to assess its biological relevance. The release of OMVs by Gram-negative bacteria is a programmed process with specific bacterial factors coordinating this process. Mutations in genes that encode proteins involved in OMV production such as pepP, ypjA, bolA, and dsbA result in hypovesiculating E. coli strains that minimally produce OMVs without a major growth defect (Kulp and Kuehn, 2010; McBroom and Kuehn, 2007; McBroom et al., 2006; Schwechheimer and Kuehn, 2013) . It should be noted that hypovesiculating strains do produce OMVs but at reduced levels. To directly test if OMVs are essential for caspase-11 activation during infections, BMDMs were infected with wild-type and hypovesiculating strains at the same MOI, and cell death and IL-1 cytokine levels were measured. Remarkably, hypovesiculating strains induced markedly decreased levels of caspase-11-dependent cell death, IL-1b, and IL-1a compared to wild-type bacteria ( Figures 6A  and S5A ). We verified that cells were infected with equivalent numbers of wild-type or mutant bacteria by agar plating (Figure S5B) . Furthermore, the inducible expression of proIL-1b, IFN-b, CCL5, TNF, CXCL10, and CCL2 as well as TLR4-dependent secretion of TNF and IL-6 were comparable between wildtype and mutant bacterial strains ( Figures S5C-S5E ). This indicates that mutant bacteria are not globally defective for innate immune activation and the defect was specific to cytosolic LPS-driven responses ( Figure 6A ). Consistent with our hypothesis, transfection of lysates of these mutants into the cytosol induced caspase-11-dependant cell death and IL-1b secretion at levels similar to wild-type bacterial lysate further confirming that the LPS in these mutants is fully functional, and the defective caspase-11 activation observed during infection with live hypovesiculating mutants is attributable to impaired cytosolic LPS delivery ( Figure 6B ). Directly supporting this, LPS levels detected in the cytosol of cells infected with hypovesiculating strains were considerably lower compared to that of wild-type bacteria-infected cells (Figures 6C and S5F) . Notably, complementation of each hypovesiculating mutant with plasmids encoding the corresponding gene restored IL-1b and cell death close to wild-type levels ( Figures 6D and 6E) . Furthermore, these hypovesiculating mutants induced lower levels of cell death compared to wild-type E. coli in HeLa cells ( Figure 6F ). In sum, these data substantiate that optimal OMV production is necessary for delivering LPS into the cytosol and activating caspase-11 during extracellular Gram-negative bacterial infections.
OMVs Activate Cytosolic LPS Sensing Pathway In Vivo
To determine if OMVs can activate the cytosolic LPS sensing pathway in vivo, wild-type and caspase-11 À/À mice were injected with purified OMVs and caspase-11 activation was assessed by measuring IL-1b, IL-1a, and IL-18 levels in plasma.
OMVs elicited IL-1b, IL-18, and IL-1a cytokine responses in wild-type mice, and these responses were significantly reduced in caspase-11 À/À mice ( Figure 7A ) demonstrating that OMVs activate caspase-11 in vivo. The production of OMVs during a wide range of human bacterial infections is clearly evident from the growing body of literature (Ellis and Kuehn, 2010) . Particularly, OMVs have been found in the serum and body fluids of patients with lethal meningococcal sepsis (Namork and Brandtzaeg, 2002; Stephens et al., 1982) . We first assessed OMV production during enteric infections using a Citrobacter rodentium infection model that closely resembles human EHEC infection (Mallick et al., 2012) . LPS-immunogold staining and TEM identified bacterial OMVs in the cecum (Figures S6A-S6C) . Strikingly, these LPS-containing vesicle-like structures closely interacted with the microvilli of enterocytes ( Figure S6D ) and appeared to be taken up by enterocytes ( Figure S6E ). More importantly, TEM also revealed the intracellular localization of LPS in the intestinal epithelial cells ( Figures S6F and S6G) .
A similar approach employed to evaluate OMV secretion during systemic E. coli infection identified OMVs in the peritoneal cavity of infected mice ( Figures 7B and S6H) . Immunogold staining using antibodies against LPS and OmpF, an outer membrane protein of E. coli and a marker for OMVs, confirmed the bacterial origin of these OMVs (Figures 7B and S6I) . Finally, to directly evaluate if OMV production is essential for eliciting caspase-11-mediated responses during bacterial infection in vivo, a hypovesiculating DypjA E. coli strain was utilized. The reduced production of OMVs by this hypovesiculating mutant in vivo was confirmed by lower levels of OmpF and LPS (OMV markers) in the OMV preparations from the peritoneal lavages of mice infected with DypjA mutant relative to wild-type E. coli ( Figures 7C  and 7D ). More importantly, plasma levels of IL-1b and IL-18 following infection with this DypjA E. coli were markedly lower compared to that of wild-type E. coli-infected mice ( Figure 7E ). This data confirmed that the optimal OMV production is a critical requirement for cytosolic LPS localization and eliciting caspase-11-mediated responses during bacterial infections in vivo as well.
DISCUSSION
Sensing of LPS in the cytosol by inflammatory caspases such as caspase-11 has emerged as a central mechanism of innate immune activation during Gram-negative bacterial infections as well as sepsis (Hagar et al., 2013; Kayagaki et al., 2013; Shi et al., 2014) . Here, we provide key mechanistic insights into a previously unknown yet critical upstream event in this pathway, the entry of LPS into the cytosol. We demonstrate that OMVs secreted by Gram-negative bacteria function as vehicles that deliver LPS into the cytosol and activate caspase-11-mediated responses in immune cells and mice. Bacteria that poorly produce OMVs elicit weak cell death and IL-1 maturation showing that OMV is a biologically relevant and essential mechanism by which LPS gains access to the cytosol during Gram-negative bacterial infections.
Our data suggest that OMVs are endocytosed by macrophages, and OMVs release LPS likely from the early endosomal (legend continued on next page) compartments into the cytosol. This proposed mechanism of early endosomal exit of OMV-LPS is consistent with the idea that early endosomes are the sorting stations for internalized cargoes; cargoes destined for degradation progress to lysosomes via late endosomes whereas other cargoes are routed to the cell surface or cytosol, where they exert their biological activity. Early endosomal escape allows OMV-bound LPS to reach cytosol functionally intact and avoid complete degradation in the lysosomes. The biophysical characteristics inherent to OMVs such as their surface lipid phase and membrane curvature perhaps permit them to fuse with the endosomal membranes ultimately leading to cytosolic access.
OMVs, like eukaryotic exosomes/microvesicles, can tightly interact with cellular membranes. As a result, OMV-bound products, particularly hydrophobic and insoluble ones (like lipids), have greater capacity than their free form to translocate across cellular membranes (Kulp and Kuehn, 2010) . Therefore, it is conceivable that OMV-associated LPS is a better candidate than free LPS for cytosolic access. Additionally, OMVs may deliver LPS as large aggregates at high concentrations locally, which could serve as a platform facilitating caspase-11 oligomerization. Thus, OMVs are at the critical interphase between host and microbes, and OMVs offer bacterial products specific access to otherwise inaccessible cellular and tissue compartments. According to the ''patterns of pathogenesis'' hypothesis, two critical determinants of the innate immune responses during an infection are the presence of live replicating bacteria and the location where PAMPs are recognized (Vance et al., 2009 ). Bacteriaderived small molecules including cyclic-di-GMP and mRNA are considered as indicators of live bacterial infections (Sander et al., 2011; Vance et al., 2009 ). OMVs are secreted by growing bacteria, and importantly, OMVs enable the cytosolic localization of PAMPs including LPS as revealed by this study. Therefore, the innate immune recognition of inflammatory PAMPs in the context of OMVs, particularly in the cytosol, would license a strong inflammatory reaction from the host. Thus, OMVs with the cargo of immunostimulatory PAMPs may represent a cardinal sign of infection with not only viable but also multiplying bacteria.
Our finding of OMV activation of cytosolic LPS sensing pathway may have significant implications for vaccine development. Owing to their high immunogenicity, OMVs are being considered as vaccine candidates against several infectious diseases. Notably, OMV-based vaccines have been licensed for meningococcal disease caused by N. meningitidis in several countries (Acevedo et al., 2014) . Additionally, OMV-based vaccines against a number of Gram-negative bacterial infections are currently under development. However, an unresolved key issue in the development of OMV vaccines is their LPS content because the contribution of LPS to immunogenicity versus toxicity of OMV vaccines is not yet clear. Therefore, future experimental evaluation of whether the activation of cytosolic LPS sensing by OMVs is beneficial or harmful in OMV vaccine applications will be key in the rational design of OMV-based vaccines and in improving their safety and adjuvanticity.
EXPERIMENTAL PROCEDURES
Mice C57BL/6 mice from The Jackson Laboratory and caspase-11 À/À mice (kind gift of Vishva Dixit and Kate Fitzgerald) were bred and maintained in specific pathogen-free conditions at the UConn Health. Animal protocols were carried out in accordance with the guidelines set forth by the Institutional Animal Care and Use Committee.
Bacterial Strains and Growth Conditions
Bacterial strains and their sources are described in the Supplemental Experimental Procedures. Bacterial strains were grown overnight in Luria Bertani broth and the macrophages were infected at an MOI of 25 unless otherwise indicated.
Purification and Characterization of Bacterial OMVs
OMVs were purified from E. coli BL21 or P. aeruginosa PAK strain as described previously with modifications (Chutkan et al., 2013) . See the Supplemental Experimental Procedures for details.
Cell Culture and Stimulations
BMDMs and BMDCs were generated as described previously (Rathinam et al., 2010) . Cells used to assess the inflammasome and cell death responses were primed with Pam3CSK4 (InvivoGen) for 3 hr unless otherwise indicated. Cells were infected with bacteria at indicated MOIs and supernatants were collected 16 hr post-stimulation unless otherwise indicated. See the Supplemental Experimental Procedures for details.
Isolation of Cytosol Fraction from BMDMs and HeLa Cells
Subcellular fractionation of BMDMs was conducted by a digitonin-based fractionation method as described previously with modifications (Ramsby and Makowski, 2005) . Briefly, 4 3 10 6 cells were infected with EHEC or treated with OMVs or left untreated, washed thoroughly, and treated with 0.005% digitonin extraction buffer for 8 min to collect the supernatant containing cytosol. The residual cell fraction containing cell membrane, organelles and nucleus was collected in 0.1% CHAPS buffer. See the Supplemental Experimental Procedures for details.
siRNA and shRNA Knockdown ON-TARGETplus SMARTpool non-targeting control, mouse AP2m1, and mouse Rab7 siRNAs (250 nM; GE Dharmacon) were reverse-transfected into immortalized BMDMs (iBMDMs; 10 4 cells) using 1 ml Interferin (Polyplus).
The transfection was repeated the next day and cells were subjected to experiments or western blotting to assess the knockdown efficiency 48 hr later. TRC lentiviral pLKO.1 vectors (GE Dharmacon) encoding eGFP (control; RHS4459), Rab5A (clones TRCN0000100795 and TRCN0000100797), or Rab7 (clones TRCN0000100880 and TRCN0000100881) shRNAs were used for stable knockdown of corresponding genes. Briefly, iBMDMs transduced with lenti virus supernatant obtained from 293T cells (72-96 hr after transfection with pLKO.1 and packaging plasmids) were puromycin-selected. The knockdown efficiency was assessed by qPCR or western blotting. ELISA and Cell Death Assay IL-1b and IL-1a levels were assessed by Ready-Set-Go! ELISA kits (eBioscience). IL-18 ELISA was performed as described previously (Bossaller et al., 2012) . Cell death was assessed by LDH cytotoxicity detection kit (Clontech) or CellTiter-Glo assay (Promega).
Confocal Microscopy
Immunoblotting and Antibodies
Immunoblotting was performed as described (Rathinam et al., 2012b) with the antibodies listed in the Supplemental Experimental Procedures.
In Vivo OMV Stimulation and Infection Eight-to 16-week-old C57BL/6 and caspase-11 À/À mice were primed with intraperitoneal (i.p.) administration of 200 mg of poly(I:C) (high molecular weight; InvivoGen) for 6 hr prior to i.p. injection with 100 mg of purified OMVs. Cytokine levels in the plasma were analyzed at 6 hr post-OMV injection. Additionally, C57BL/6 mice were infected with 10 9 CFU of wild-type or DypjA E. coli strains at exponential phase of growth, and plasma cytokine levels were analyzed at 12 hr post-infection.
Statistical Analysis
In vitro data were analyzed for statistical significance by one-way or two-way ANOVA followed by the Sidak's post-test with Prism Software. Data from in vivo experiments were analyzed by Mann-Whitney test. P values of <0.05 were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures and six figures and can be found with this article online at http://dx.doi.org/ 10.1016/j.cell.2016.04.015.
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